About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Baltimore | 13,698 Studies Near You

Clinical TrialsBaltimore

Clinical Trials in Baltimore

Discover 13,698 clinical trials near Baltimore, Maryland. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 2981-3000 of 13,698 trials

TerminatedCombination Chemotherapy With or Without Chemoembolization in Treating Patients With Colorectal Cancer Metastatic to the Liver (6655)RATIONALE: Drugs used in chemotherapy, such as irinotecan, fluorouracil, and leucovorin, work in different ways to stop the growth of cancer cells, either by killing the cells or…NCT00023868·Tucson, Arizona and 8 others TerminatedA Stratified Sickle Event Randomized Trial (ASSERT)The purpose of this study is to compare the effects of ICA-17043 to placebo with or without hydroxyurea (an oral drug used for treatment of sickle cell disease) in patients with…NCT00102791·Mobile, Alabama and 48 others

Find Trials by Condition in Baltimore

Breast Cancerin Baltimore Lung Cancerin Baltimore Prostate Cancerin Baltimore Colorectal Cancerin Baltimore Melanomain Baltimore Leukemiain Baltimore Lymphomain Baltimore Pancreatic Cancerin Baltimore Ovarian Cancerin Baltimore Brain Cancerin Baltimore

Data from ClinicalTrials.govTerms

CompletedA Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With SchizophreniaThe objective of this study is to evaluate the efficacy and safety of cariprazine relative to placebo in the prevention of relapse of symptoms in participants with schizophrenia.NCT01412060·Little Rock, Arkansas and 72 others

Active not recruitingA Study Comparing Talquetamab in Combination With Daratumumab or in Combination With Daratumumab and Pomalidomide Versus Daratumumab in Combination With Pomalidomide and Dexamethasone in Participants With Multiple Myeloma That Returns After Treatment or is Resistant to TreatmentThe purpose of the study is to compare the efficacy of talquetamab subcutaneous(ly) (SC) in combination with daratumumab SC and pomalidomide (Tal-DP) and talquetamab SC in…NCT05455320·Tucson, Arizona and 215 others

Active not recruitingUsing CBPR to Engage Hazardous Drinking Women in the HIV Prevention and Care ContinuumUnhealthy alcohol use among women with and at risk for HIV can interrupt critical steps in the HIV prevention and care continuum, is associated with HIV transmission risk…NCT04090723·Baltimore, Maryland

RecruitingFabry Disease Registry & Pregnancy Sub-registryThe Fabry Registry is an ongoing, international multi-center, strictly observational program that tracks the routine clinical outcomes for patients with Fabry disease…NCT00196742·Birmingham, Alabama and 283 others

CompletedClinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH)The purpose of this study is to see whether droxidopa is effective in treating symptoms of neurogenic orthostatic hypotension in patients with Primary Autonomic Failure (Pure…NCT00633880·Birmingham, Alabama and 53 others

RecruitingEvaluation of Xaluritamig in Adults, Adolescents and Children With Relapsed or Refractory Ewing Sarcoma (EWS)The main objectives of this trial are to determine the recommended dose for expansion of xaluritamig (dose confirmation part only) and to determine the safety and tolerability of…NCT07297979·Los Angeles, California and 10 others

CompletedStudy of CP-675,206 in Refractory MelanomaCP-675,206 is a fully human monoclonal antibody (mAb). It binds to the CTLA4 molecule, which is expressed on the surface of activated T lymphocytes.NCT00254579·Scottsdale, Arizona and 64 others

CompletedComparison of Two Pulmonary Embolism TreatmentsThe primary objective of this trial is to evaluate the safety and efficacy of treatment with anticoagulation alone versus anticoagulation and mechanical aspiration thrombectomy…NCT05684796·Tucson, Arizona and 21 others

RecruitingTesting the Pain Clinical Practice GuidelineThere are evidence based processes for assessment and management of pain using pharmacologic and nonpharmacological approaches.NCT05858996·Baltimore, Maryland and 10 others

RecruitingMulti-Site Detection of Barrett's Esophagus in Patients Without Chronic GERD SymptomsThe goal of this clinical trial is to develop a method to detect Barrett's esophagus in individuals with a new office based diagnostic test.NCT06687603·Aurora, Colorado and 4 others

CompletedRisk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic LeukemiaThis research trial studies a risk-based classification system for patients with newly diagnosed acute lymphoblastic leukemia.NCT01142427·Birmingham, Alabama and 243 others

CompletedA Study of CK-2127107 in Patients With Spinal Muscular AtrophyThis study will evaluate the pharmacodynamic (PD) effect of CK-2127107 (hereafter referred to as reldesemtiv) versus placebo on measures of skeletal muscle function or…NCT02644668·Los Angeles, California and 18 others

CompletedEffects of Nicotine on Elements of Attentions in Smokers and NonsmokersBackground: \- Many cigarette smokers claim that smoking helps them stay alert and improves their concentration, and have reported problems in attention and concentration after…NCT01034020·Baltimore, Maryland

RecruitingStudy of Senaparib in Combination With Temozolomide in ARID1A Mutation Associated Ovarian CancerThis is a phase 2 study to test the effectiveness (anti-tumor activity) of the combination of the study drugs, Senaparib and Temozolomide, in patients with clear cell or…NCT06617923·Baltimore, Maryland and 1 other

Active not recruitingA Phase 1, Dose-Escalation Trial of PT2385 Tablets In Patients With Advanced Clear Cell Renal Cell Carcinoma (MK-3795-001)PART 1: The primary objective of this study is to identify the maximum tolerated dose (MTD) of MK-3795, formerly called PT2385 and/or the recommended Phase 2 dose (RP2D) of…NCT02293980·Los Angeles, California and 24 others

CompletedA Study of Food Effect and Esomeprazole on LY4064809 in Healthy Adult ParticipantsThe purpose of this study is to evaluate the safety and effect of food on LY4064809 and the safety and effect of stomach changes by a proton pump inhibitor (PPI) esomeprazole…NCT06991179·Baltimore, Maryland

TerminatedPhase III Study With Idebenone in Patients With Duchenne Muscular Dystrophy (SIDEROS-E)The purpose of the study is to assess the long-term safety and efficacy of idebenone in patients with Duchenne muscular dystrophy (DMD) who completed the SIDEROS study.NCT03603288·Birmingham, Alabama and 38 others

CompletedAcute Medically Ill VTE Prevention With Extended Duration Betrixaban Study (The APEX Study)The purpose of this study is to evaluate whether extended prophylaxis with oral betrixaban can prevent blood clots in the leg and lung that sometime occur in patients hospitalized…NCT01583218·Birmingham, Alabama and 461 others

PreviousPage 150 of 685Next

Diabetes

in Baltimore

Heart Diseasein Baltimore